Public Investment Fund’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-227,177
Closed -$55M 57
2025
Q2
$55M Sell
227,177
-127,208
-36% -$31.2M 0.23% 40
2025
Q1
$96.5M Hold
354,385
0.38% 35
2024
Q4
$65.5M Hold
354,385
0.24% 35
2024
Q3
$79.6M Hold
354,385
0.3% 31
2024
Q2
$50.6M Hold
354,385
0.24% 33
2024
Q1
$55.4M Hold
354,385
0.27% 31
2023
Q4
$63.9M Hold
354,385
0.18% 41
2023
Q3
$63.7M Buy
354,385
+36,700
+12% +$7.26M 0.17% 42
2023
Q2
$56.6M Hold
317,685
0.15% 44
2023
Q1
$68.5M Hold
317,685
0.19% 42
2022
Q4
$69.9M Hold
317,685
0.23% 42
2022
Q3
$42.8M Hold
317,685
0.12% 46
2022
Q2
$51.4M Hold
317,685
0.12% 45
2022
Q1
$59.9M Hold
317,685
0.14% 31
2021
Q4
$86.1M Sell
317,685
-177,704
-36% -$60M 0.15% 29
2021
Q3
$180M Buy
+495,389
New +$162M 0.41% 19

Other funds holding ONC

Public Investment Fund's ONC Position: Q3 2025 in Review

Public Investment Fund sold out of BeOne Medicines Ltd (ONC) in Q3 2025, closing a stake of 227,177 shares — an estimated $55M sold.

Public Investment Fund first reported a position in ONC in Q3 2021 and held it in 16 quarters. The position peaked at $180M in Q3 2021. 265 funds tracked by Wall St. Rank hold ONC as of Q3 2025.

  • Public Investment Fund reported no remaining BeOne Medicines Ltd position as of Q3 2025 after selling out during the quarter.
  • Public Investment Fund sold 227,177 BeOne Medicines Ltd shares in Q3 2025, an estimated $55M.
  • Public Investment Fund first reported a position in BeOne Medicines Ltd in Q3 2021 and held it in 16 quarters.
  • Public Investment Fund's BeOne Medicines Ltd position peaked at $180M in Q3 2021.
  • 265 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2025.

Based on Public Investment Fund's 13F filing for Q3 2025, filed 14 Nov 2025.